Filing Details
- Accession Number:
- 0001562180-21-000307
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-12 16:48:38
- Reporting Period:
- 2021-01-08
- Accepted Time:
- 2021-01-12 16:48:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1590877 | Regenxbio Inc. | RGNX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1521123 | J. Patrick Christmas | C/O Regenxbio Inc. 9600 Blackwell Road, Suite 210 Rockville MD 20850 | Chief Legal Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-01-08 | 10,000 | $12.10 | 26,372 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-08 | 4,618 | $46.43 | 21,754 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-01-08 | 4,062 | $47.42 | 17,692 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-01-08 | 1,320 | $48.13 | 16,372 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-01-11 | 7,500 | $12.10 | 23,872 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-01-11 | 2,622 | $19.50 | 26,494 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-11 | 10,122 | $49.08 | 16,372 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-01-12 | 1,378 | $19.50 | 17,750 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-12 | 1,378 | $49.15 | 16,372 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2021-01-08 | 10,000 | $0.00 | 10,000 | $12.10 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2021-01-11 | 7,500 | $0.00 | 7,500 | $12.10 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-01-11 | 2,622 | $0.00 | 2,622 | $19.50 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-01-12 | 1,378 | $0.00 | 1,378 | $19.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 29,931 | 2026-08-17 | No | 4 | M | Direct | |
| 22,431 | 2026-08-17 | No | 4 | M | Direct | |
| 2,019 | 2027-01-03 | No | 4 | M | Direct | |
| 641 | 2027-01-03 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- This transaction was executed in multiple trades at prices ranging from $45.86 to $46.84. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $46.87 to $47.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $47.87 to $48.74. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $49.00 to $49.42. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $49.00 to $49.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The previously granted option, representing a right to purchase a total of 125,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on August 18, 2017, and the balance vested in equal monthly installments over the 36 months thereafter.
- The previously granted option, representing a right to purchase a total of 11,100 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 4, 2018, and the balance vested in equal monthly installments over the 36 months thereafter.
Billionaire Hedge Funds
